- Home
- ACV vs CADL Comparison
ACV vs CADL Comparison
Compare ACV & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACV
- CADL
- Stock Information
- Founded
- ACV 2015
- CADL 1999
- Country
- ACV United States
- CADL United States
- Employees
- ACV N/A
- CADL N/A
- Industry
- ACV Finance/Investors Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ACV Finance
- CADL Health Care
- Exchange
- ACV Nasdaq
- CADL Nasdaq
- Market Cap
- ACV 253.6M
- CADL 265.7M
- IPO Year
- ACV N/A
- CADL 2021
- Fundamental
- Price
- ACV $24.79
- CADL $6.30
- Analyst Decision
- ACV
- CADL Strong Buy
- Analyst Count
- ACV 0
- CADL 6
- Target Price
- ACV N/A
- CADL $20.33
- AVG Volume (30 Days)
- ACV 38.8K
- CADL 777.9K
- Earning Date
- ACV 01-01-0001
- CADL 11-13-2025
- Dividend Yield
- ACV 9.20%
- CADL N/A
- EPS Growth
- ACV N/A
- CADL N/A
- EPS
- ACV N/A
- CADL N/A
- Revenue
- ACV N/A
- CADL N/A
- Revenue This Year
- ACV N/A
- CADL N/A
- Revenue Next Year
- ACV N/A
- CADL N/A
- P/E Ratio
- ACV N/A
- CADL N/A
- Revenue Growth
- ACV N/A
- CADL N/A
- 52 Week Low
- ACV $16.82
- CADL $3.79
- 52 Week High
- ACV $23.74
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ACV 65.36
- CADL 56.70
- Support Level
- ACV $23.44
- CADL $5.38
- Resistance Level
- ACV $24.39
- CADL $5.73
- Average True Range (ATR)
- ACV 0.32
- CADL 0.30
- MACD
- ACV -0.01
- CADL 0.08
- Stochastic Oscillator
- ACV 73.68
- CADL 90.62
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.